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Purpose: Transforming growth factor β (TGFb) is associated with many corneal pathologies, 
diseases and dystrophies. The function of TGFb in adult corneas cannot be studied using conventional 
transgenic approach because TGFb1 and TGFb2 deficient transgenic animals suffer multiple 
inflammatory diseases, severe developmental defects, and death by 3-4 weeks of age. This study 
tested the hypothesis that selective tissue-targeted gene transfer approaches will permit examination of 
TGFb gene function in the adult cornea without altering TGFb expression in vital organs. 
Methods: Female black C57 mice were used. Animals were anesthetized with intramuscular 
injection of ketamine (130mg/kg) and xylazine (8.8mg/kg). Topical solution of 1% proparacaine 
hydrochloride was instilled to each eye for local anesthesia. Two microliters of AAV5 naked vector 
or expressing TGFb1 gene (titer 109 genomic copies/µl) was administered into the cornea. Eyes 
were collected at various time-points post-AAV application. Visual eye exam, stereomicroscopy, 
and slit-lamp biomicroscopy were used to monitor corneal health. Immunocytochemistry, western 
blotting and real-time PCR techniques were used to study corneal tissues.
Results: Tissue-selective targeted delivery of TGFβ1 gene via AAV5 induced haze and opacity 
in the mouse cornea in a time-dependent manner as evident from slit-lamp biomicroscopy and 
preliminary immunocytochemistry experiments. Experiments are underway to study expression 
of collagens, extracellular matrix proteins and signaling pathways linked to TGFβ-mediated 
pathologies.
Conclusions: Tissue-specific controlled gene transfer approaches are a powerful tool to study 
gene function and identify therapeutic targets for mechanism-based innovative therapies to treat 
and prevent corneal abnormalities. 
